By Gabriel Paijo 
A comprehensive meta-analysis conducted by researchers from the University of Surrey, the John Innes Centre, and the Quadram Institute Bioscience has uncovered a significant and previously unknown physiological interaction between the two primary forms of vitamin D. The study, published in the peer-reviewed journal Nutrition Reviews, indicates that supplementation with vitamin D2 (ergocalciferol) may lead to a measurable decline in the body’s levels of vitamin D3 (cholecalciferol), which is the form of the vitamin most effectively utilized by humans. This discovery challenges long-standing assumptions about the interchangeability of these two supplements and suggests that vitamin D3 is the superior choice for supporting both skeletal health and immune function.
Vitamin D is a critical micronutrient, functioning more as a pro-hormone than a traditional vitamin. It is essential for the absorption of calcium and phosphorus, making it a cornerstone of bone health. In the United Kingdom, where sunlight—the primary source of vitamin D—is insufficient for synthesis during the winter months (October through March), the government recommends a daily intake of 10 micrograms (400 IU) for the entire population. However, the choice between vitamin D2, which is typically derived from plant and fungal sources, and vitamin D3, which is animal-derived or synthesized in the skin via UVB radiation, has remained a point of clinical debate. The new findings suggest that this choice is more consequential than previously realized.
The Scientific Distinction Between Vitamin D2 and Vitamin D3
To understand the implications of the Surrey study, it is necessary to examine the biochemical differences between the two forms. Vitamin D2 is produced by fungi and yeast through the irradiation of ergosterol. Because it is plant-based, it has traditionally been the primary option for vegetarians and vegans. Vitamin D3, conversely, is synthesized in the skin of humans and animals when exposed to sunlight (specifically UVB rays) or consumed through animal products like oily fish, egg yolks, and liver.
While both forms are converted by the liver into 25-hydroxyvitamin D [25(OH)D]—the standard biomarker used to measure a person’s vitamin D status—they are not processed with equal efficiency. Previous research has suggested that vitamin D3 is more effective at raising and maintaining serum 25(OH)D levels over a longer period. The current research goes a step further, demonstrating that taking D2 does not merely result in a slower rise in total vitamin D levels but can actively deplete the levels of circulating D3.
Analysis of the Research: The Displacement Effect
The research team, led by Emily Brown, a PhD Research Fellow at the University of Surrey, performed a systematic review and meta-analysis of data from multiple randomized controlled trials. These trials compared the effects of vitamin D2 and vitamin D3 supplementation on the blood levels of study participants.
The data revealed a consistent trend: individuals taking vitamin D2 supplements experienced a reduction in their natural vitamin D3 concentrations compared to those in the control groups. Strikingly, in several of the analyzed studies, the vitamin D3 levels in the D2-supplemented group dropped lower than those who were taking no supplement at all. This suggests a "displacement" or "interference" effect, where the presence of high levels of D2 might accelerate the catabolism (breakdown) of D3 or compete for the same transport proteins and enzymes required for activation.
"Vitamin D supplements are important, especially between October and March, when our bodies cannot make vitamin D from sunlight in the UK," stated Emily Brown. "However, we discovered that vitamin D2 supplements can actually decrease levels of vitamin D3 in the body, which is a previously unknown effect of taking these supplements. This study suggests that subject to personal considerations, vitamin D3 supplements may be more beneficial for most individuals over vitamin D2."
Chronology of Vitamin D Research and Public Health Guidelines
The understanding of vitamin D has evolved significantly over the last century. In the early 20th century, the focus was primarily on rickets, a bone-deforming disease in children caused by severe deficiency. By the mid-1900s, the fortification of milk and cereals became common in many Western nations.
In 2016, the Scientific Advisory Committee on Nutrition (SACN) in the UK updated its guidelines, moving from recommending vitamin D only for "at-risk" groups to recommending it for everyone over the age of four. This shift was prompted by the realization that a significant portion of the British population had serum levels below 25 nmol/L, the threshold for deficiency.
The recent focus has shifted from bone health to the "extra-skeletal" effects of vitamin D, particularly its role in the immune system. This shift was accelerated by the COVID-19 pandemic, which sparked global interest in how micronutrients might influence viral resistance. The Surrey study builds upon this timeline by providing more granular detail on how the specific form of the vitamin influences these outcomes.
Differential Impact on Immune Function
A pivotal aspect of this research involves a previous study led by Professor Colin Smith, also from the University of Surrey, and published in Frontiers in Immunology. This earlier work utilized transcriptomics to analyze gene expression in participants taking either D2 or D3.
The findings were stark: vitamin D3 was found to have a profound effect on the immune system, specifically stimulating the Type I interferon signaling system. This system is the body’s "first responder" to viral and bacterial invasions, triggering a cellular defense mechanism that prevents pathogens from replicating. In contrast, vitamin D2 did not show the same stimulatory effect on these specific immune pathways.
"We have shown that vitamin D3, but not vitamin D2, appears to stimulate the type I interferon signalling system in the body," explained Professor Colin Smith. "A healthy vitamin D3 status may help prevent viruses and bacteria from gaining a foothold in the body."
This suggests that for individuals taking vitamin D specifically to bolster their immune health during flu and cold seasons, D2 may provide a false sense of security while simultaneously lowering the more "immunologically active" D3 levels.
Implications for the Food Industry and Plant-Based Diets
The discovery that D2 might be counterproductive to D3 levels poses a challenge for the growing plant-based food sector. Historically, vitamin D2 has been the go-to choice for fortifying vegan-friendly products because most vitamin D3 is sourced from lanolin (sheep’s wool).
Professor Cathie Martin, Group Leader at the John Innes Centre, emphasized the need for innovation in this area. "This meta-analysis highlights the importance of ensuring plant-based vitamin D3 is accessible in the UK," she noted.
In recent years, the industry has begun to develop plant-based D3 sourced from lichen or algae. Furthermore, research into bio-fortified crops, such as gene-edited tomatoes that naturally accumulate provitamin D3, offers a potential solution to ensure that vegetarians and vegans can access the more effective form of the nutrient without compromising their ethical stances.
Public Health Response and Expert Analysis
The Quadram Institute, a center for food and health research, has integrated these findings into its broader mission of improving national health through nutritional density. Professor Martin Warren, Chief Scientific Officer at the Quadram Institute, highlighted the urgency of the issue.
"Vitamin D deficiency represents a significant public health concern, especially during the winter months with significant deficiency across the UK population," Professor Warren said. "Tackling this with the most effective form of vitamin D supplementation or fortification is of the utmost importance to the health of the nation."
From a clinical perspective, the data suggests a need for a shift in how vitamin D status is monitored. Many standard blood tests measure "Total 25(OH)D," which combines D2 and D3. If D2 is indeed displacing the more effective D3, a patient might appear to have "sufficient" levels on a standard test while their immune-critical D3 levels are actually depleted.
Broader Impact and Future Directions
The implications of this research extend beyond the UK. Vitamin D deficiency is a global pandemic, affecting an estimated one billion people worldwide. In northern latitudes, where the "vitamin D winter" lasts for several months, the reliance on supplements and fortified foods is absolute.
If further research confirms that D2 consistently interferes with D3 metabolism, it could lead to a significant re-evaluation of global fortification strategies. Current practices in many countries allow for either D2 or D3 to be used in products like orange juice, bread, and milk alternatives. A regulatory shift toward D3 could improve public health outcomes, particularly regarding respiratory tract infections and autoimmune stability.
The research team has called for further investigation into the specific functionalities of D2 versus D3. Priority areas for future study include:
- Identifying the exact molecular mechanism by which D2 reduces D3 levels.
- Determining if the displacement effect is dose-dependent.
- Investigating whether specific populations (e.g., the elderly or those with chronic kidney disease) are more susceptible to this interaction.
For now, the consensus among the researchers involved is clear: while any form of vitamin D is better than a deficiency, vitamin D3 appears to be the superior choice for those seeking to maximize the health benefits of supplementation. As the scientific community continues to unravel the complexities of human nutrition, the "one size fits all" approach to vitamins is increasingly being replaced by a more nuanced, evidence-based understanding of how specific nutrient forms interact with our biology.